help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

A more recent version of this article appeared on December 1, 2007

Published online before print November 30, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ajpath.2007.070318v1
171/6/1822    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, J.-A.
Right arrow Articles by Adler, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, J.-A.
Right arrow Articles by Adler, K. B.
Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.070318


Accepted for publication September 10, 2007.


Article

Protein Kinase C{delta} Regulates Airway Mucin Secretion via Phosphorylation of MARCKS Protein

Jin-Ah Park*{dagger}, Anne L. Crews*, William R. Lampe*, Shijing Fang*, Joungjoa Park*, and Kenneth B. Adler*@

From the Department of Molecular Biomedical Sciences,* College of Veterinary Medicine, and the Department of Environmental and Molecular Toxicology,{dagger} College of Agriculture and Life Sciences, North Carolina State University, Raleigh, North Carolina

@ To whom correspondence should be addressed. E-mail: kenneth_adler{at}ncsu.edu.


   Abstract

Mucin hypersecretion is a major pathological feature of many respiratory diseases, yet cellular mechanisms regulating secretion of mucin have not been fully elucidated. Previously, we reported that mucin hypersecretion induced by human neutrophil elastase involves activation of protein kinase C (PKC), specifically the {delta}-isoform (PKC{delta}). Here, we further investigated the role of PKC{delta} in mucin hypersecretion using both primary human bronchial epithelial cells and the human bronchial epithelial 1 cell line as in vitro model systems. Phorbol-12-myristate-13-acetate (PMA)-induced mucin hypersecretion was significantly attenuated by rottlerin, a PKC{delta}-selective inhibitor. Rottlerin also reduced PMA- or human neutrophil elastase-induced phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) protein in these cells. Both secretion and MARCKS phosphorylation were significantly enhanced by the PKC{delta} activator bryostatin 1. A dominant-negative PKC{delta} construct (pEGFP-N1/PKC{delta}K376R) transfected into human bronchial epithelial 1 cells significantly attenuated both PMA-induced mucin secretion and phosphorylation of MARCKS, whereas transfection of a wild-type construct increased PKC{delta} and enhanced mucin secretion and MARCKS phosphorylation. Similar transfections of a dominant-negative or wild-type PKC{epsilon} construct did not affect either mucin secretion or MARCKS phosphorylation. The results suggest that PKC{delta} plays an important role in mucin secretion by airway epithelium via regulation of MARCKS phosphorylation.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society for Investigative Pathology.